For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
4
views
0
references
 Top references
cited by
7
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To evaluate intravitreal bevacizumab (IVB) injection efficacy for the treatment of chronic, atypical, or recurrent central serous chorioretinopathy (CSC).

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Retina (Philadelphia, Pa.)
          Title: Retina (Philadelphia, Pa.)
          Publisher: Ovid Technologies (Wolters Kluwer Health)
          ISSN (Electronic): 1539-2864
          ISSN (Print): 0275-004X
          Publication date (Electronic): Jan 2019
          Volume: 39
          Issue: 1
          Affiliations
          [1 ] Department of Ophthalmology, Ajou University School of Medicine, Suwon, Republic of Korea.
          [2 ] Department of Ophthalmology, Armed Forces Capital Hospital, Seongnam, Republic of Korea.
          Article
          DOI: 10.1097/IAE.0000000000001917
          PubMed ID: 29077604
          SO-VID: 76759f0c-1c2d-432d-9a8b-752a6a927a20
          History

          Data availability:

          Comments

          Comment on this article